Back to search
Rejection of Kidney Allograft
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Rejection of Kidney Allograft trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Rejection of Kidney Allograft trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of this study is to evaluate the benefits and risks of conversion of existing adolescent kidney allograft recipients aged 12 to less than 18 years o…
Chronic Allograft Nephropathy (CAN)/Interstitial fibrosis and Tubular Atrophy (IFTA) is responsible for most kidney transplant failures. CAN/IFTA on a 3 month k…
The goal of the Australian Genomics of Chronic Allograft Dysfunction (AUSCAD) study is a single centre (Westmead Hospital), prospective, observational study, wh…
This clinical trial investigates the transplantation of donor kidneys that have been genetically modified ex vivo using CRISPR-Cas9 genome editing to reduce imm…
This study will evaluate the safety, PK, and efficacy of AT 1501 in patients undergoing kidney transplantation.
Microvascular inflammation in kidney allografts has been widely reappraised in the recent update of Banff classification. There is a critical need to better und…
The goal of the global Phase 1/2 clinical trial is to evaluate whether CID-103, a novel anti-CD38 monoclonal antibody, is safe and effective in adults with with…
This study was to compare CFZ533 to tacrolimus (TAC) in prevention of organ rejection in kidney transplant.